Analyst Price Target is $25.00
▲ +284.62% Upside Potential
This price target is based on 1 analysts offering 12 month price targets for ImmunityBio in the last 3 months. The average price target is $25.00, with a high forecast of $25.00 and a low forecast of $25.00. The average price target represents a 284.62% upside from the last price of $6.50.
Current Consensus is
The current consensus among 1 investment analysts is to buy stock in ImmunityBio.